Pharming (PHAR) Gains from Investment Securities (2020 - 2025)
Historic Gains from Investment Securities for Pharming (PHAR) over the last 4 years, with Q2 2023 value amounting to -$442000.0.
- Pharming's Gains from Investment Securities changed N/A to -$442000.0 in Q2 2023 from the same period last year, while for Jun 2023 it was $3.0 million, marking a year-over-year change of. This contributed to the annual value of -$2658.0 for FY2020, which is 9995.35% up from last year.
- Per Pharming's latest filing, its Gains from Investment Securities stood at -$442000.0 for Q2 2023.
- Over the past 5 years, Pharming's Gains from Investment Securities peaked at $3.4 million during Q3 2022, and registered a low of -$5.6 million during Q4 2019.
- For the 4-year period, Pharming's Gains from Investment Securities averaged around -$1.1 million, with its median value being -$442000.0 (2023).
- Over the last 5 years, Pharming's Gains from Investment Securities had its largest YoY gain of 9995.09% in 2020, and its largest YoY loss of 9995.09% in 2020.
- Pharming's Gains from Investment Securities (Quarter) stood at -$5.6 million in 2019, then soared by 99.95% to -$2773.3 in 2020, then skyrocketed by 123313.02% to $3.4 million in 2022, then tumbled by 112.94% to -$442000.0 in 2023.
- Its last three reported values are -$442000.0 in Q2 2023, $3.4 million for Q3 2022, and -$2773.3 during Q4 2020.